Health & Wellness

Press Releases

Dr. Missak Haigentz, Researcher in Head and Neck and Lung Cancer, Appointed Chief of Hematology and Oncology, Morristown Medical Center

Dr. Missak Haigentz

Dr. Haigentz’s Newly Reported Studies at ASCO Show Promise for Head and Neck, Lung Cancer Patients and Cancer Patients with HIV

 Morristown, NJ – Nationally renowned head and neck and lung cancer researcher Missak Haigentz, MD, has joined Atlantic Health System Cancer Care as chief of hematology and oncology at Morristown Medical Center and medical director of Atlantic Hematology and Oncology for Atlantic Medical Group at the Carol G. Simon Cancer Center.  Dr. Haigentz, a cancer physician who has extensive expertise in the design and implementation of innovative clinical trials to improve the lives of cancer patients, was the lead or co-author of major studies presented at the recent annual scientific meeting of the American Society of Clinical Oncology (ASCO).  ASCO is the world's leading professional organization for physicians caring for people with cancer.

“Dr. Haigentz is a leader in head and neck cancer research, treatment and education,” said Eric Whitman, MD, medical director, Atlantic Health System Cancer Care.  “We are proud that he has chosen to join our Cancer Care team.  His appointment enhances Atlantic Health System’s capabilities in clinical trials for head and neck cancers, as well as for lung cancer.  He also brings with him extensive experience in using the most innovative, targeted cancer treatments and immunotherapy, which we will now be able to offer to our patients.” 

Sign Up for E-News

Dr. Haigentz joins Atlantic Health System from the National Cancer Institute-designated Albert Einstein Cancer Center in New York City, where he served as director of the clinical trials office and led several national and multicenter trials of cancer drugs.  He most recently held the academic rank of professor of medicine (oncology) and otorhinolaryngology – head and neck surgery at the Albert Einstein College of Medicine, with which the Albert Einstein Cancer Center is affiliated. 

“Atlantic Health System is known for its strong leadership commitment to innovation, clinical research, patient-centered care, and to bringing the latest treatments to cancer patients,” said Dr. Haigentz.  “Therefore, as a longtime New Jersey resident, AHS Cancer Care was the natural choice for me in terms of making an impact on patients’ treatment outcomes in my community.  As medical director of Atlantic Hematology and Oncology, my goal is to provide subspecialty-specific cancer care at an academic level, with access to clinical trials and breakthrough medications, while preserving the comfort of compassionate and individualized attention patients and families need and deserve, and to collaborate with outstanding multidisciplinary specialists in the Atlantic Health System Cancer Care team in providing the most innovative and effective therapeutic options.”

Recently returned from the ASCO meeting, Dr. Haigentz’s studies reported there covered a variety of cancer treatments and treatment related issues, including: the first analysis of patient survival data from a multicenter Phase III study of a drug combination that included bevacizumab (Avastin®) for people with advanced head and neck cancer; an early stage study of whether certain cancer patients who are living with HIV can tolerate a combination treatment of paclitaxel (Taxol®) and carboplatin (Paraplatin®); whether there were racial/ethnic disparities in lung cancer patient treatment with immunotherapies; and a long-term analysis of the risks and benefits of Phase I clinical trials. 


Background on Dr. Haigentz

A passionate physician, clinical researcher, educator and leader, Dr. Haigentz is recognized nationally and internationally as an expert in cancers of the head and neck, including thyroid cancers, and in lung cancers. His research has received funding from the National Institutes of Health and the Conquer Cancer Foundation of ASCO. He is the author of numerous peer-reviewed manuscripts, review articles and book chapters, and he has served on the editorial board of the Journal of Clinical Oncology. He has held several leadership roles, including service as president of the New York Head and Neck Society (2014-2015). Throughout his career, Dr. Haigentz has taken pride in providing compassionate and personalized cancer care.

Dr. Haigentz earned his undergraduate degree at the University of California, Los Angeles in 1991 and his medical degree from the New Jersey Medical School in 1995. After completing residency training in internal medicine at New Jersey Medical School in 1998 (where he also served as chief resident), he received subspecialty fellowship training in hematology and oncology at the New York University School of Medicine. In 2001, Dr. Haigentz was recruited to the faculty of the Albert Einstein College of Medicine, where he rose to the rank of professor of medicine (oncology) and otorhinolaryngology - head & neck surgery.

Dr. Haigentz sees patients at the Atlantic Hematology Oncology practice at the Carol G. Simon Cancer Center - Morristown Medical Center campus at 100 Madison Avenue in Morristown.  Dr. Haigentz can be reached at 973-971-7960.

TAP Into Another Town's News:

You May Also Be Interested In

Sign Up for E-News


MorrisTech Meetup Receives Award from Morris County EDC

March 20, 2018

FLORHAM PARK, NJ - The innovative and technology driven MorrisTech Meetup has been awarded the 2017 Non-Profit of the Year Award by the Morris County Economic Development Corporation.

"We are thrilled, proud and grateful to receive this award, and convinced more than ever that Morris County is exceptionally suited to be a thriving tech hub", said founder, Chatham ...

Pine Brook Massage Parlor Shut Down After Several Failed Inspections

March 19, 2018

MONTVILLE, NJ – A used prophylactic in the trash, apparent “table showers,” and the implication of employees sleeping and cooking in the Swan Lake Spa massage parlor in Pine Brook resulted in the spa’s license revocation at a hearing held by the Board of Health March 12.

The spa had been in business on Route 46 since 2012 and had been subject to a revised 2012 ordinance ...

JCP&L Preparing for Third Nor’easter that Could Impact Region

March 20, 2018

Jersey Central Power & Light (JCP&L) is preparing for the third nor’easter to hit the region in the past two weeks that could produce more than a foot of heavy, wet snow and the potential for wind gusts up to 45 mph in its northern and central New Jersey service areas beginning early Wednesday. 

JCP&L personnel have implemented storm and staffing plans and are prepared ...

Upcoming Events

Thu, March 22, 5:00 PM

The Mansion at Mountain Lakes, Mountain Lakes

St. Mary's Prep Tricky Tray

Food & Drink

Sat, March 24

Black Diamond Billiard's, Union

Ladies 9-Ball Pro-Am by the Garden State Pool Tour

Other Sports

'Trying' explores age, youth and points of history in poignant production

‘Trying’ explores youth, age and points of history in poignant production

By Liz Keill

NEW BRUNSWICK, NJ – The George Street Playhouse presents an engrossing, two-character play based on the real life of Francis Biddle, former Attorney General.

Biddle, a Harvard educated lawyer, served under Franklin Roosevelt and later Harry Truman during the Nuremberg Tribunal. His ...


AtlantiCast: Episode 13

On this episode of AtlantiCast, new clinical studies in the fields of cardiology and immunotherapy, national and statewide recognitions for Atlantic Health System medical centers and the inaugural AtlantiCast Collab Challenge!


In Cold Blood by Truman Capote

In Cold Blood by Truman Capote (Random House, 1965)


In Cold Blood is, quite simply, the grand-daddy of true crime writing, dubbed by Capote, himself, as the first non-fiction novel (although Norman Mailer argued the point when he published The Executioner's Song in 1979.) The conditions under which I read In Cold Blood for the first time were pretty weird, which was another ...

Ian Hockley Visits New Jersey to Introduce Program to Empower Youth

This week I am taking a departure from book reviewing to share an important program that has been introduced to New Jersey this week by Mr. Ian Hockley, founder of the Dylan's Wings of Change Foundation. On December 14, 2012, Hockley's five year old son, an autistic child named Dylan, was gunned down in his classroom in the Sandy Hook Elementary School shooting. Dylan, a shy and adorable ...